Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 1683 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 169
  1. Net price*
    Year
  2. $495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    ICT budget forecasts in Medium-sized Austrian Manufacturers - Estimated ICT budget breakdowns in 2013

    Kable Global ICT Intelligence
    19 pages
    SynopsisThis report illustrates how Kable expects Medium-sized Austrian Manufacturers to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.SummaryWhy was the report written?This report presents the output from Kable's ICT spend prediction sta
    Englisch | Databook | SKU: 332359
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Haemophilus Influenzae Type b Infections – Pipeline Review, H1 2013

    Global Markets Direct
    48 pages
    Introduction Global Markets Direct’s, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Haemophilus Influenzae Type b Infections, complete with latest updates, and special features on
    Englisch | Report | SKU: 329717
  4. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Burns – Pipeline Review, H1 2013

    Global Markets Direct
    90 pages
    Introduction Global Markets Direct’s, 'Burns - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Burns, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invo
    Englisch | Report | SKU: 403861
  5. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Obesity - Canada Drug Forecast and Market Analysis to 2022

    GlobalData
    111 pages
    After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 401829
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    VLP Biotech, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    19 pages
    Global Market Direct’s pharmaceuticals report, “VLP Biotech, Inc. - Product Pipeline Review - 2013” provides data on the VLP Biotech, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report
    Englisch | Zukunftsanalyse | SKU: 386420
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Renal Cell Carcinoma – Pipeline Review, H1 2013

    Global Markets Direct
    334 pages
    Introduction Global Markets Direct’s, 'Renal Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Renal Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It
    Englisch | Report | SKU: 318886
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Soft Tissue Sarcoma – Pipeline Review, H1 2013

    Global Markets Direct
    220 pages
    Introduction Global Markets Direct’s, 'Soft Tissue Sarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Soft Tissue Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It a
    Englisch | Report | SKU: 329781
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Chronic Heart Failure – Pipeline Review, H1 2013

    Global Markets Direct
    51 pages
    Introduction Global Markets Direct’s, 'Chronic Heart Failure - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects.
    Englisch | Report | SKU: 318598
  10. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022

    GlobalData
    136 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AE
    Englisch | Report | SKU: 330279
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Ensemble Therapeutics Corporation - Product Pipeline Review - 2013

    Global Markets Direct
    26 pages
    Global Market Direct’s pharmaceuticals report, “Ensemble Therapeutics Corporation - Product Pipeline Review - 2013” provides data on the Ensemble Therapeutics Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued a
    Englisch | Zukunftsanalyse | SKU: 386484

Items 1 to 10 of 1683 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 169